(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 6.14% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.81%.
Revvity's revenue in 2026 is $2,813,367,000.On average, 23 Wall Street analysts forecast RVTY's revenue for 2026 to be $343,414,756,009, with the lowest RVTY revenue forecast at $323,460,646,713, and the highest RVTY revenue forecast at $356,906,454,908. On average, 22 Wall Street analysts forecast RVTY's revenue for 2027 to be $361,101,352,885, with the lowest RVTY revenue forecast at $342,054,248,557, and the highest RVTY revenue forecast at $379,014,701,003.
In 2028, RVTY is forecast to generate $382,302,594,012 in revenue, with the lowest revenue forecast at $359,400,718,570 and the highest revenue forecast at $404,410,840,107.